Literature DB >> 2895001

Characterization of dopamine-induced potassium efflux in rat parotid acinar cells.

S Sundström1, A Danielsson, R Henriksson, P Lindström.   

Abstract

The effects of dopamine and noradrenaline on potassium efflux from rat parotid gland were studied in a perifusion system. Tissue specimens were preincubated with 86RbCl and the efflux of 86Rb+ was used as a marker for potassium efflux. Noradrenaline induced 86Rb+ efflux more effectively than dopamine. The noradrenaline-induced efflux was inhibited by alpha-adrenoceptor blockers, especially the alpha 1-antagonist prazosin. The dopamine-induced 86Rb+ efflux was blocked by alpha-adrenoceptor antagonists, non-selective dopamine antagonists and a D-1 selective dopamine antagonist. The D-2 selective drug, sulpiride, did not affect the dopamine-induced 86Rb+ efflux. The dopamine effect was abolished when reserpinized animals were used, whereas the effect of noradrenaline was unaffected. The results suggest that dopamine has a presynaptic stimulatory effect in rat parotid gland, and that the presynaptic effect on potassium efflux seems to be mediated via the D-1 receptor subtype. Whether activation of the presynaptic D-1 receptors leads to noradrenaline release, or whether the D-1 receptor is coupled to the catecholamine transporter system remains to be studied further.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2895001     DOI: 10.1016/0014-2999(88)90223-3

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  2 in total

1.  Dopamine actions in vitro on enzyme and electrolyte secretion from normal and sympathectomized rat parotid glands.

Authors:  A Danielsson; R Henriksson; S Sundström; P Wester
Journal:  J Physiol       Date:  1988-10       Impact factor: 5.182

2.  Potassium channels involved in the transduction mechanism of dopamine D2 receptors in rat lactotrophs.

Authors:  L Castelletti; M Memo; C Missale; P F Spano; A Valerio
Journal:  J Physiol       Date:  1989-03       Impact factor: 5.182

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.